Fragmin and Zantac drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Fragmin (dalteparin sodium) and Zantac (ranitidine hydrochloride). Common drug interactions include atrial fibrillation among females and febrile neutropenia among males.
The phase IV clinical study analyzes what interactions people have when they take Fragmin and Zantac. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.
What is Fragmin?
Fragmin has active ingredients of dalteparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 11,999 Fragmin users. Check the latest studies of Fragmin.
What is Zantac?
Zantac has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 434,161 Zantac users. Check the latest studies of Zantac.
93 people who take Fragmin and Zantac together, and have interactions are studied.

What are the common drug interactions of Fragmin and Zantac, by gender? *:
female:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
- Cardiac failure
- Dyspnoea exertional (breathlessness or shortness of breath)
- Epistaxis (bleed from the nose)
- Febrile neutropenia (fever with reduced white blood cells)
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Haematemesis (vomiting of blood)
- Hepatic vein occlusion (blockage of the hepatic vein)
- Hydronephrosis (water inside the kidney)
male:
- Febrile neutropenia (fever with reduced white blood cells)
- Alanine aminotransferase increased
- Tonsillitis (inflammation of tonsil)
- Aspartate aminotransferase increased
- Collapse of lung (functional breakdown of lung)
- Cystitis (inflammation of the wall of the bladder)
- Dyspnoea (difficult or laboured respiration)
- Gamma-glutamyltransferase increased
- Headache (pain in head)
- Hepatic vein occlusion (blockage of the hepatic vein)
What are the common drug interactions of Fragmin and Zantac, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Acute respiratory distress syndrome
- Epistaxis (bleed from the nose)
- Haematemesis (vomiting of blood)
- Nausea (feeling of having an urge to vomit)
- Pulmonary haemorrhage (acute bleeding from the lung)
- Vomiting
- Blood pressure decreased
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Pulmonary oedema (fluid accumulation in the lungs)
10-19:
- Febrile neutropenia (fever with reduced white blood cells)
- Hepatic vein occlusion (blockage of the hepatic vein)
- Alanine aminotransferase increased
- Anaemia (lack of blood)
- Arrhythmia (irregular heartbeat)
- Cardiac failure
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Hyperbilirubinaemia (excess of bilirubin in the blood)
- Hyperglycaemia (high blood sugar)
- Hypoaesthesia (reduced sense of touch or sensation)
20-29:
- Drug hypersensitivity
- Tonsillitis (inflammation of tonsil)
- Urinary tract infection
- Cystitis (inflammation of the wall of the bladder)
- Febrile neutropenia (fever with reduced white blood cells)
- Neutropenia (an abnormally low number of neutrophils)
- Headache (pain in head)
30-39:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Gamma-glutamyltransferase increased
- Blood lactate dehydrogenase increased
- Blood alkaline phosphatase nos increased
- Delivery
- Drug exposure during pregnancy
- Right ventricular failure (right half of the heart fails to work)
40-49:
- Myalgia (muscle pain)
- Pain
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Pruritus (severe itching of the skin)
- Chest pain
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Diarrhoea
- Disease progression
- Dysgeusia (disorder of the sense of taste)
- Dyspnoea (difficult or laboured respiration)
50-59:
- Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
- Thrombocythaemia (an increased number of platelets in the circulating blood)
- Thrombosis (formation of a blood clot inside a blood vessel)
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
- Dyspnoea (difficult or laboured respiration)
- Pelvic pain
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Pyrexia (fever)
- Constipation
- Hypercalcaemia (elevated calcium (ca+) level in the blood)
60+:
- Impaired healing
- Postoperative wound complication
- Muscular weakness (muscle weakness)
- Pain
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Upper respiratory tract infection
- Adult respiratory distress syndrome (type of lung (pulmonary) failure)
- Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Blood pressure diastolic increased
What are the existing conditions these people have? *
- Pain: 16 people, 17.20%
- Indigestion: 11 people, 11.83%
- Sedation: 10 people, 10.75%
- High Blood Pressure: 8 people, 8.60%
- Traumatic Haemorrhage (a bleeding due to trauma): 7 people, 7.53%
- Nausea (feeling of having an urge to vomit): 7 people, 7.53%
- Immunodeficiency Disorders: 6 people, 6.45%
- Constipation: 6 people, 6.45%
- Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 5 people, 5.38%
- Skin Ulcer: 5 people, 5.38%
* Approximation only. Some reports may have incomplete information.
Do you take Fragmin and Zantac?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Fragmin and Zantac:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Fragmin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zantac:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fragmin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zantac and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dalteparin sodium and ranitidine hydrochloride (the active ingredients of Fragmin and Zantac, respectively), and Fragmin and Zantac (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Colestipol Hydrochloride vs. Omega-3 Fatty Acid, side effect and effectiveness comparison - now
- Could Diprivan cause Gastric Ulcer? - 8 seconds ago
- Could Ciprofloxacin cause Chronic Fatigue Syndrome? - 12 seconds ago
- Sleep Apnea in Losartan Potassium, how severe and when it was recovered? - 22 seconds ago
- Could Sertraline cause Hyponatraemic Encephalopathy? - 27 seconds ago
- Could Fentanyl Citrate cause Cuts And Puncture Wounds? - 33 seconds ago
- Norco vs. Meperidine Hydrochloride, side effect and effectiveness comparison - 42 seconds ago
- Could Proventil cause Osteoarthritis? - 44 seconds ago
- Zipsor vs. Enbrel, side effect and effectiveness comparison - a minute ago
- Muscle Atrophy and drugs of ingredients of insulin aspart recombinant - a minute ago